Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rang in aandelen #23
Johnson & Johnson is a holding company, which engages in the research,... Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Aandeelprijs
$267.84
Marktkapitalisatie
$645.47B
Verandering (1 dag)
-0.63%
Verandering (1 jaar)
51.68%
Land
US
Handel Johnson & Johnson (JNJ)

Categorie

EPS voor Johnson & Johnson (JNJ)
EPS per June 2026 TTM: $8.65
Volgens de laatste financiële rapporten en de aandelenkoers van Johnson & Johnson is de huidige EPS van het bedrijf (TTM) $8.65. Eind 2024 had het bedrijf een EPS van $5.84, een stijging ten opzichte van de EPS van 2023 die $13.88 bedroeg.
EPS-geschiedenis van Johnson & Johnson van 2000 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
2026 (TTM) $8.65 -21.58%
2025 $11.03 88.87%
2024 $5.84 -57.93%
2023 $13.88 75.03%
2022 $7.93 41.86%
2021 $5.59 -2.61%
2019 $5.74 -0.17%
2018 $5.75 1,097.92%
2017 $0.48 -92.11%
2016 $6.08 9.16%
2015 $5.57 -4.95%
2014 $5.86 19.59%
2013 $4.90 25.32%
2012 $3.91 10.45%
2011 $3.54 -27.16%
2010 $4.86 9.21%
2009 $4.45 -4.71%
2008 $4.67 27.25%
2007 $3.67 -2.39%
2006 $3.76 11.24%
2005 $3.38 22.91%
2004 $2.75 13.64%
2003 $2.42 10.00%
2002 $2.20 17.65%
2001 $1.87 13.33%
2000 $1.65 0.00%
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
$29.89 245.55%
US
$3.55 -58.96%
US
$20.39 135.71%
CH
$1.26 -85.43%
US
$7.19 -16.88%
CH